Citigroup
LENZ

Citigroup’s LENZ Therapeutics LENZ Stock Holding History

Citigroup’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.5K Buy
11,180
+6,379
+133% +$51.4K ﹤0.01% 4899
2026
Q1 		$43.9K Sell
4,801
-10,151
-68% -$143K ﹤0.01% 4570
2025
Q4 		$239K Buy
14,952
+7,671
+105% +$224K ﹤0.01% 3915
2025
Q3 		$339K Sell
7,281
-1,649
-18% -$60.6K ﹤0.01% 3759
2025
Q2 		$262K Sell
8,930
-781
-8% -$21.2K ﹤0.01% 3937
2025
Q1 		$250K Sell
9,711
-7,742
-44% -$191K ﹤0.01% 4066
2024
Q4 		$504K Buy
17,453
+8,306
+91% +$253K ﹤0.01% 3823
2024
Q3 		$217K Sell
9,147
-9,318
-50% -$207K ﹤0.01% 4283
2024
Q2 		$319K Buy
18,465
+17,715
+2,362% +$309K ﹤0.01% 3651
2024
Q1 		$16.7K Buy
750
+170
+29% +$3.53K ﹤0.01% 5084
2023
Q4 		$10.6K Buy
580
+475
+452% +$7.84K ﹤0.01% 5183
2023
Q3 		$1.82K Sell
105
-1,228
-92% -$21.4K ﹤0.01% 4988
2023
Q2 		$24.3K Buy
1,333
+1,238
+1,303% +$24.7K ﹤0.01% 4912
2023
Q1 		$1.62K Sell
95
-10,070
-99% -$163K ﹤0.01% 5113
2022
Q4 		$236K Buy
10,165
+10,051
+8,817% +$233K ﹤0.01% 3635
2022
Q3 		$3K Sell
114
-491
-81% -$11.7K ﹤0.01% 5428
2022
Q2 		$12K Buy
605
+264
+77% +$5.88K ﹤0.01% 5297
2022
Q1 		$12K Sell
341
-488
-59% -$30.5K ﹤0.01% 5452
2021
Q4 		$72K Buy
829
+559
+207% +$46.3K ﹤0.01% 4903
2021
Q3 		$31K Buy
+270
New +$40K ﹤0.01% 5014

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Citigroup's LENZ Position: Q2 2026 in Review

Citigroup increased its LENZ Therapeutics (LENZ) stake by 133% in Q2 2026, buying an estimated $51.4K and bringing the position to 11,180 shares worth $63.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4899.

Citigroup first reported a position in LENZ in Q3 2021 and has held it in 20 quarters since. The position peaked at $504K in Q4 2024. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Citigroup held 11,180 shares of LENZ Therapeutics worth $63.5K as of Q2 2026.
  • Citigroup bought 6,379 LENZ Therapeutics shares in Q2 2026, an estimated $51.4K.
  • LENZ Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4899 holding.
  • Citigroup first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Citigroup's LENZ Therapeutics position peaked at $504K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.